=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-14
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: GE HealthCare Technologies Inc. (GEHC)
CIK: 0001932393
--- Reporting Owner ---
Name: Grogan William K
CIK: 0001694002
Role: Officer (Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock, par value $0.01 per share
Date: 2026-09-14 | Code: A (Grant or award)
Shares: +62,256 | Price: $0.00
Shares Owned After: 62,256 | Ownership: D (Direct)
Footnotes:
[F1] Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on September 14, 2027, and 50% will vest on September 14, 2028.
[F2] Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
[Transaction #2]
Security: Common Stock, par value $0.01 per share
Date: 2026-09-14 | Code: A (Grant or award)
Shares: +12,840 | Price: $0.00
Shares Owned After: 75,096 | Ownership: D (Direct)
Footnotes:
[F2] Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
[F3] Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
--- Derivative Transactions ---
[Transaction #1]
Security: Employee Stock Option (right to buy)
Date: 2026-09-14 | Code: A (Grant or award)
Shares: +31,877 | Price: $0.00
Exercise Price: $64.25
Exercisable: N/A | Expires: 2036-09-14
Shares Owned After: 31,877 | Ownership: D (Direct)
Footnotes:
[F4] Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
[F4] Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
--- Footnotes (Complete Index) ---
F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on September 14, 2027, and 50% will vest on September 14, 2028.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
F4: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
--- Signature ---
/s/ /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact (2026-09-16)
